Baloxavir and oseltamivir for severe flu in immune-compromised people
Treatments studied
Part of Blood & lymphatic, Cancer, Infections, Lungs & breathing clinical trials.
This trial tests whether two flu medicines—baloxavir and oseltamivir—work better to treat influenza in people with weakened immune systems (like transplant or blood cancer patients). It may help reduce severe complications, especially when flu affects the lungs or is at high risk to do so.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’ve had a stem cell (hematopoietic) transplant or you have a blood cancer
- You have confirmed flu on a PCR test (a lab test from a swab confirming influenza)
- Your flu illness shows signs of lung involvement, or it’s high-risk in the upper nose/throat even without lung signs
- You can take medicines by mouth (no major trouble swallowing or absorbing oral meds)
- You’re not on certain other flu antivirals or herbal flu treatments that are not allowed
- You are not needing a breathing machine and you can consent to the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 2 study compares antiviral medicines in adults who have early, flu-like symptoms and test positive for influenza. It aims to see which antiviral treatment works best and is safe for people treated soon after symptoms start.
This study tests how well a single-dose flu treatment (baloxavir marboxil) works for children with the flu and whether it stops the flu from spreading to family members. If your child has early flu symptoms and lives with others, participation could help protect your household.
This trial tests two flu medicines—Tamiflu and Xofluza—to see if they can prevent flu in people who are staying in a hospital room with a patient who has the flu. You may join if you are a hospitalized close contact (roommate or caregiver) and test negative for flu.
This trial tests if taking suraxavir marboxil or oseltamivir can stop the flu from spreading to people sharing a hospital room with a patient who has the flu.
This study tests a new liquid medicine called suraxavir marboxil for children with the flu. It aims to see if the medicine safely reduces flu symptoms and helps kids recover faster.
This trial tests whether a higher dose of flu vaccine works better than the standard dose for people who have had a lung transplant. It may help improve protection against seasonal flu while monitoring safety.
Hear when a new Hematopoietic and Lymphoid Cell Neoplasm trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.